Loading...
NRXP NRX Pharmaceuticals
Loading...
News
Nrx Pharmaceuticals Inc shares rose 5.03% in afternoon trading.
At 01:40 on October 28th, Beijing time, Nrx Pharmaceuticals Inc (NRXP.us) shares changed, and the share price rose rapidly by 5.03%. As of press time, the stock was trading at US $10.45 per share, with a turnover of 514255 shares, a turnover rate of 0.96% and an amplitude of 6.45%. Recent earnings data show that the stock achieved operating income of $0.00, net profit of-$893718.00, earnings per share of-$0.33, gross profit of $0.00, and price-to-earnings ratio of-17.56 times. In terms of agency rating
Relief Therapeutics' Subsidiary Posts Early Data For Nasal Spray COVID-19 Treatment
Relief Therapeutics Holding SA's (OTC:RLFTF) wholly-owned subsidiary, APR Applied Pharma Research SA, has reported interim results from its clinical trial of nasal spray Sentinox in COVID-19.Relief al
Nrx Pharmaceuticals Inc shares rose 5.03% to $10.14 in intraday trading.
At 21:33 on October 26th, Beijing time, Nrx Pharmaceuticals Inc (NRXP.us) shares changed, and the share price rose sharply by 5.03%. As of press time, the stock was trading at US $10.14 per share, with a turnover of 63389 shares, a turnover rate of 0.12% and an amplitude of 3.21%. Recent earnings data show that the stock achieved operating income of $0.00, net profit of-$893718.00, earnings per share of-$0.33, gross profit of $0.00, and price-to-earnings ratio of-16.59 times. In terms of agency rating
Nrx Pharmaceuticals Inc shares fell 6.82% to $9.23 in intraday trading.
At 21:32 on October 25th, Beijing time, Nrx Pharmaceuticals Inc (NRXP.us) shares changed, and the share price fell sharply by 6.82%. As of press time, the stock was trading at US $9.23 per share, with a turnover of 110699 shares, a turnover rate of 0.21% and an amplitude of 3.24%. Recent earnings data show that the stock achieved operating income of $0.00, net profit of-$893718.00, earnings per share of-$0.33, gross profit of $0.00 and price-earnings ratio of-15.50 times. In terms of agency rating
Nrx Pharmaceuticals Inc shares fell 6.02% to $10.00 in intraday trading.
21:32 on October 22nd, Beijing time, Nrx Pharmaceuticals Inc (NRXP.us) shares changed, and the share price plunged 6.02%. As of press time, the stock was trading at US $10.00 per share, with a turnover of 186657 shares, a turnover rate of 0.35% and an amplitude of 3.26%. Recent earnings data show that the stock achieved operating income of $0.00, net profit of-$893718.00, earnings per share of-$0.33, gross profit of $0.00, and price-to-earnings ratio of-17.06 times. In terms of agency rating
BRIEF-NRX Pharmaceuticals Entered Into Shareholder Agreement With Shimshon Hen And David Sepiashvili
Oct 21 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :* NRX PHARMACEUTICALS INC - ENTERED INTO A SHAREHOLDER AGREEMENT WITH SHIMSHON HEN AND DAVID SEPIASHVILI* NRX PHARMACEUTICALS INC - AGREEMENT FOR
Nrx Pharmaceuticals Inc intraday movements quickly fell 5.12 percent to $10.52.
At 00:38 on October 22nd, Beijing time, Nrx Pharmaceuticals Inc (NRXP.us) shares fluctuated and fell rapidly by 5.12%. As of press time, the stock was trading at US $10.52 per share, with a turnover of 884229 shares, a turnover rate of 1.64% and an amplitude of 8.84%. Recent earnings data show that the stock achieved operating income of $0.00, net profit of-$893718.00, earnings per share of-$0.33, gross profit of $0.00, and price-to-earnings ratio of-17.75 times. In terms of agency rating
IQVIA net income more than doubles in Q3 as company raises 2021 guidance
IQVIA Holdings (NYSE:IQV) reported strong Q3 2021 results as the life sciences analytics and clinical research company more than doubled its net income year-over-year. Net income increased ~142% to $
Jasper Therapeutics, 23andMe leads healthcare gainers; Grove, Myomo among major losers
Gainers: Jasper Therapeutics (NASDAQ:JSPR) +22%, 23andMe (NASDAQ:ME) +21%, DBV Technologies (NASDAQ:DBVT) +10%, ABVC BioPharma (NASDAQ:ABVC) +10%, Sonoma Pharmaceuticals (NASDAQ:SNOA) +8%Losers: Grove
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Sonoma Pharmaceuticals (NASDAQ:SNOA) shares moved upwards by 29.96% to $7.72 during Friday's pre-market session. The company's market cap stands at $20.8 million.Avadel Pharmaceuticals (NASD